Radiolabeled Peptide as Diagnostic, Therapeutic, and Theranostic agents for Prostate Cancer: Systematic Literature Review. (2022). Pharmaceutical Reports, 1(1). https://doi.org/10.33096/pharmrep.v1i1.174